Cavernous sinus metastasis in head and neck cancer: Focus on oral squamous cell cancer

E. Segna,F. Civita,N. Denaro,G.A. Beltramini
DOI: https://doi.org/10.1016/j.oraloncology.2024.106784
IF: 5.972
2024-04-11
Oral Oncology
Abstract:Intracranial metastatic disease is rarely found in head and neck cancer (HNC), in particular, cavernous sinus (CS) involvement is difficult to recognize, because of its rarity, not specific symptoms associated and challenging imaging features. We report our experience in 4 cases, reviewing also the English literature. We analysed data from 21 patients showing that CS metastasis is a dramatic event, with rapid onset, usually starting with neurological manifestations (ophthalmoplegia, headache and trigeminal dysesthesia) and almost unavoidable outcome (DOD in 18/21 patients). Furthermore, we assessed that the diagnostic confirmation could be difficult to perform because of the need for multiple exams and time consuming procedures. Unfortunately, usual antineoplastic therapies seem to be not effective in prolonging survival, also because patients are already weakened by primary tumour treatments. The only option that seems useful in improving outcomes is immunotherapy.
dentistry, oral surgery & medicine,oncology
What problem does this paper attempt to address?